GABAergic Mechanisms of Hippocampal Hyperactivity in Schizophrenia

Overview

Journal Schizophr Res

Specialty Psychiatry

Date 2014 Dec 3

PMID 25449711

Citations 135

Authors

Stephan Heckers

Christine Konradi

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is associated with abnormalities of hippocampal structure and function. Neuroimaging studies have shown that the hippocampus is hyperactive in schizophrenia. Here we explore GABAergic mechanisms of this hippocampal hyperactivity. The initial evidence for GABAergic abnormalities of the hippocampus in schizophrenia came from post-mortem studies of interneuron number, protein expression, and gene expression. These studies revealed marked decreases in gene and protein expression of somatostatin-positive and parvalbumin-positive interneurons, and indicated reduced interneuron numbers. Animal studies of decreased parvalbumin and NMDA-receptor function have shown that selective abnormalities of hippocampal interneurons mimic some of the cognitive deficits and clinical features of schizophrenia. The post-mortem and animal studies are consistent with the neuroimaging finding of increased hippocampal activity in schizophrenia, which can explain some of the psychotic symptoms and cognitive deficits. Taken together, these findings may guide the development of biomarkers and the development of new treatments for psychosis.

Citing Articles

Perinatal Hypoxia and Immune System Activation in Schizophrenia Pathogenesis: Critical Considerations During COVID-19 Pandemic.

Kawikova I, Hakenova K, Lebedeva M, Kleteckova L, Jakob L, Spicka V Physiol Res. 2024; 73(S2):S615-S639.

PMID: 39589306 PMC: 11627263.

A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-naïve first episode psychosis patients.

Nelson E, Kraguljac N, Bashir A, Cofield S, Maximo J, Armstrong W Mol Psychiatry. 2024; .

PMID: 39580605 DOI: 10.1038/s41380-024-02812-1.

Intrinsic Infant Hippocampal Function Supports Inhibitory Processing.

Guha A, Hunter S, Legget K, McHugo M, Hoffman M, Tregellas J Dev Psychobiol. 2024; 66(6):e22529.

PMID: 39010701 PMC: 11254329. DOI: 10.1002/dev.22529.

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

Uliana D, Lisboa J, Gomes F, Grace A Biochem Pharmacol. 2024; 228:116298.

PMID: 38782077 PMC: 11410545. DOI: 10.1016/j.bcp.2024.116298.

Aberrant connectivity in the hippocampus, bilateral insula and temporal poles precedes treatment resistance in first-episode psychosis: a prospective resting-state functional magnetic resonance imaging study with connectivity concordance mapping.

Skouras S, Kleinert M, Lee E, Hui C, Suen Y, Camchong J Brain Commun. 2024; 6(3):fcae094.

PMID: 38707706 PMC: 11069118. DOI: 10.1093/braincomms/fcae094.

References

Jessen F, Scheef L, Germeshausen L, Tawo Y, Kockler M, Kuhn K . Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry. 2003; 160(7):1305-12. DOI: 10.1176/appi.ajp.160.7.1305. View

Tallent M, Qiu C . Somatostatin: an endogenous antiepileptic. Mol Cell Endocrinol. 2008; 286(1-2):96-103. PMC: 2843391. DOI: 10.1016/j.mce.2007.12.004. View

Margarita Behrens M, Ali S, Dao D, Lucero J, Shekhtman G, Quick K . Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007; 318(5856):1645-7. DOI: 10.1126/science.1148045. View

Klausberger T, Somogyi P . Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science. 2008; 321(5885):53-7. PMC: 4487503. DOI: 10.1126/science.1149381. View

Lodge D, Behrens M, Grace A . A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 2009; 29(8):2344-54. PMC: 2754752. DOI: 10.1523/JNEUROSCI.5419-08.2009. View

Ongur D, Cullen T, Wolf D, Rohan M, Barreira P, Zalesak M . The neural basis of relational memory deficits in schizophrenia. Arch Gen Psychiatry. 2006; 63(4):356-65. DOI: 10.1001/archpsyc.63.4.356. View

Benes F . Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol Psychiatry. 1999; 46(5):589-99. DOI: 10.1016/s0006-3223(99)00136-5. View

Konradi C, Zimmerman E, Yang C, Lohmann K, Gresch P, Pantazopoulos H . Hippocampal interneurons in bipolar disorder. Arch Gen Psychiatry. 2010; 68(4):340-50. PMC: 3197787. DOI: 10.1001/archgenpsychiatry.2010.175. View

Schmitt A, Steyskal C, Bernstein H, Schneider-Axmann T, Parlapani E, Schaeffer E . Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathol. 2008; 117(4):395-407. DOI: 10.1007/s00401-008-0430-y. View

10.

Gur R, Mozley P, Resnick S, Mozley L, Shtasel D, Gallacher F . Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gen Psychiatry. 1995; 52(8):657-67. DOI: 10.1001/archpsyc.1995.03950200047013. View

11.

Wragg R, Jeste D . Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry. 1989; 146(5):577-87. DOI: 10.1176/ajp.146.5.577. View

12.

Stone J, Dietrich C, Edden R, Mehta M, De Simoni S, Reed L . Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol Psychiatry. 2012; 17(7):664-5. PMC: 3883303. DOI: 10.1038/mp.2011.171. View

13.

Heckers S, Heinsen H, Geiger B, Beckmann H . Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry. 1991; 48(11):1002-8. DOI: 10.1001/archpsyc.1991.01810350042006. View

14.

Small S, Schobel S, Buxton R, Witter M, Barnes C . A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 2011; 12(10):585-601. PMC: 3312472. DOI: 10.1038/nrn3085. View

15.

Perez S, Lodge D . Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia. Mol Psychiatry. 2013; 18(11):1193-8. PMC: 4028118. DOI: 10.1038/mp.2013.111. View

16.

Venables P . Hippocampal function and schizophrenia. Experimental psychological evidence. Ann N Y Acad Sci. 1992; 658:111-27. DOI: 10.1111/j.1749-6632.1992.tb22841.x. View

17.

Lodge D, Grace A . Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia. Behav Brain Res. 2009; 204(2):306-12. PMC: 2736136. DOI: 10.1016/j.bbr.2009.01.031. View

18.

Schobel S, Lewandowski N, Corcoran C, Moore H, Brown T, Malaspina D . Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry. 2009; 66(9):938-46. PMC: 2797730. DOI: 10.1001/archgenpsychiatry.2009.115. View

19.

Bartos M, Vida I, Jonas P . Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 2006; 8(1):45-56. DOI: 10.1038/nrn2044. View

20.

Kawasaki Y, Maeda Y, Sakai N, Higashima M, Yamaguchi N, Koshino Y . Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structures. Psychiatry Res. 1996; 67(1):49-58. DOI: 10.1016/0925-4927(96)02685-6. View